Propanc Biopharma, Inc. Common Stock Strategic Asset Allocation Index
Propanc Biopharma, Inc. Common Stock strategic asset allocation index. Propanc Biopharma, Inc. Common Stock (PPCB) has a Strategic Asset Allocation Index of 0.3% as of March 2012. Strategic assets (PP&E of $5.00K plus long-term investments of $-) total $5.00K, measured against net assets of $1.68 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Propanc Biopharma, Inc. Common Stock (PPCB) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Propanc Biopharma, Inc. Common Stock Strategic Asset Allocation Index by Year (None–None)
Propanc Biopharma, Inc. Common Stock strategic asset allocation index by year from None to None. The table below presents the year-by-year Strategic Asset Allocation Index for Propanc Biopharma, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PPCB stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|